ArticleCyborg and bionic systems (Washington, D.C.)2024
Camera-Radar Fusion with Modality Interaction and Radar Gaussian Expansion for 3D Object Detection.
Article in Cyborg and bionic systems (Washington, D.C.), 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
8 citing papers in PubMed.
- Dynamic Object Detection in Maritime Navigation Scenarios Based on Vision-Radar Fusion.Sensors (Basel, Switzerland) · 2026Article
- An efficient camouflaged image segmentation with modified UNet and attention techniques.Scientific reports · 2025Article
- A review of robotic and automated systems in meat processing.Frontiers in robotics and AI · 2025Review
- Self-Powered Multimodal Tactile Sensing Enabled by Hybrid Triboelectric and Magnetoelastic Mechanisms.Cyborg and bionic systems (Washington, D.C.) · 2025Article
- A detection method for synchronous recognition of string tomatoes and picking points based on keypoint detection.Frontiers in plant science · 2025Article
- A robust detect and describe framework for object recognition in early childhood education.PeerJ. Computer science · 2025Article
- Camera-Radar Fusion with Radar Channel Extension and Dual-CBAM-FPN for Object Detection.Sensors (Basel, Switzerland) · 2024Article
- Parallel Driving with Big Models and Foundation Intelligence in Cyber-Physical-Social Spaces.Research (Washington, D.C.) · 2024Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
The fusion of millimeter-wave radar and camera modalities is crucial for improving the accuracy and completeness of 3-dimensional (3D) object detection. Most existing methods extract features from each modality separately and conduct fusion with specifically designed modules, potentially resulting in information loss during modality transformation. To address this issue, we propose a novel framework for 3D object detection that iteratively updates radar and camera features through an interaction module. This module serves a dual purpose by facilitating the fusion of multi-modal data while preserving the original features. Specifically, radar and image features are sampled and aggregated with a set of sparse 3D object queries, while retaining the integrity of the original radar features to prevent information loss. Additionally, an innovative radar augmentation technique named Radar Gaussian Expansion is proposed. This module allocates radar measurements within each voxel to neighboring ones as a Gaussian distribution, reducing association errors during projection and enhancing detection accuracy. Our proposed framework offers a comprehensive solution to the fusion of radar and camera data, ultimately leading to heightened accuracy and completeness in 3D object detection processes. On the nuScenes test benchmark, our camera-radar fusion method achieves state-of-the-art 3D object detection results with a 41.6% mean average precision and 52.5% nuScenes detection score.
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.